Hanny Al-Samkari, M.D. is a classical hematologist and leading international clinical investigator in hemostasis, platelet disorders, and hemolytic anemias. His focus is on the development of novel therapeutics in hereditary hemorrhagic telangiectasia, immune thrombocytopenia, chemotherapy-induced thrombocytopenia and hemolytic anemia. He serves as global principal investigator for many ongoing studies in these areas.